Mechanism of action of exosomes in the development and progression of hepatitis B virus-related chronic hepatitis and hepatocellular carcinoma
10.3969/j.issn.1001-5256.2022.09.034
- VernacularTitle:外泌体在慢性乙型肝炎和HBV相关肝细胞癌发生发展中的作用机制
- Author:
Ziwei GUO
1
,
2
;
Hening CHEN
1
,
2
;
Xu CAO
1
,
2
;
Jiaxin ZHANG
1
;
Ningyi ZHANG
1
,
2
;
Qian JIN
1
,
2
;
Xiaoke LI
1
;
Yongan YE
1
Author Information
1. Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China
2. The First Clinical Medical College of Beijing University of Chinese Medicine, Beijing 100029, China
- Publication Type:Reviews
- Keywords:
Exosomes;
Hepatitis B Virus;
Hepatitis B, Chronic;
Carcinoma, Hepatocellular;
Pathologic Processes
- From:
Journal of Clinical Hepatology
2022;38(9):2125-2129
- CountryChina
- Language:Chinese
-
Abstract:
Exosomes (EXOs) are formed by intracellular multivesicular bodies and carry a variety of biomacromolecules such as lipids, proteins, encoding and non-coding RNAs, and mitochondrial DNA. EXOs can be released in vivo by different cell types, including hepatocytes, hepatic stellate cells, and immune cells and play the role of intercellular communication. More and more studies have shown that EXOs are involved in the development, progression, and prognosis of chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC) caused by hepatitis B virus (HBV) infection and are expected to become potential biomarkers for the early diagnosis and prognostic evaluation of HBV-related HCC. This article reviews the role of EXOs in the host infection process of HBV and the importance of EXOs in the development, progression, and prognosis of CHB and HCC, in order to provide new ideas for the basic and clinical research in this field.
